Clinical Trial Update: A Phase 2 Study of CRD-4730 in CPVT [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating CRD-4730 for catecholaminergic polymorphic ventricular tachycardia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Catecholaminergic Polymorphic Ventricular Tachycardia

Drugs mentioned

• CRD-4730

Snippet

Sponsor: Cardurion Pharmaceuticals, Inc. | Conditions: Catecholaminergic Polymorphic Ventricular Tachycardia | Phase 2 | Status: RECRUITING